The emergence of metatine, a synthetic derivative of nicotine known scientifically as 6-methyl-nicotine, has raised alarms among health advocates and anti-tobacco organizations. The Comité national contre le tabagisme (CNCT) has highlighted the substance's presence in vaping products and oral pouches, warning of its potential to be up to three times more addictive than traditional nicotine. This development comes as the vaping industry seeks innovative ways to attract consumers, particularly younger demographics, amidst tightening regulations on nicotine products.

According to the CNCT, metatine's high addictive potential is not its only concern. Preliminary research suggests that the substance may also induce the production of reactive oxygen species in the lungs, leading to inflammation and damage with unknown long-term effects. The organization has criticized the vaping industry for promoting products containing metatine under misleading claims of being healthier alternatives to traditional smoking, a practice it deems as illicit advertising.

The legal landscape surrounding metatine remains ambiguous. While not explicitly banned in Europe, the substance does not meet the regulatory requirements for evaluation and notification, effectively prohibiting its use in commercial products. Despite this, metatine has been detected in various vaping products and oral pouches across France and other parts of Europe, prompting calls for stricter enforcement of existing laws.

In response to these concerns, the CNCT has announced legal action against Aroma King, a manufacturer accused of marketing products containing metatine. The case underscores the ongoing battle between public health advocates and the tobacco and vaping industries over the regulation of novel substances designed to circumvent existing laws. As the debate over metatine's safety and legality continues, consumers are urged to exercise caution and stay informed about the potential risks associated with new vaping products.